SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Marie Curie — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMarie Curie
Date of birth1867-11-07
IdentifiersMRN HR-ET013-SYN-TD; SSN (made up) 000-13-2758
Document date1934-06-08
AuthorAdaeze Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-week review on immunosuppressive therapy, and glare in the right eye. [S]

History of Present Illness

Madame Curie returns three weeks after starting horse antithymocyte globulin, cyclosporine, eltrombopag, and acyclovir. She completed the four-day antithymocyte globulin course. She takes cyclosporine twice daily, eltrombopag on an empty stomach away from dairy, and acyclovir twice daily, and has missed no doses. She has had no fever, chills, sore mouth, rash, or joint pain, and no new bleeding beyond occasional bruises. She still tires by midafternoon and is writing at home on shortened days. Glare from the right eye makes small print and night driving difficult, and it is slowing her reading. [S]

ElementDetail
TreatmentAntithymocyte globulin course completed; cyclosporine, eltrombopag, and acyclovir taken as prescribed
InfectionNo fever, chills, or sore mouth
BleedingOccasional bruises; no mucosal bleeding
FunctionTired by midafternoon; writing at home on shortened days
VisionRight-eye glare slowing her reading; night driving difficult

Review of Systems

SystemResultFinding
ConstitutionalPositiveFatigue by midafternoon; no fever or chills
HematologicPositiveOccasional bruises; no mucosal bleeding
EyesPositiveGlare and blurred reading vision in the right eye; no pain or flashes
SkinNegativeNo rash
MusculoskeletalNegativeNo joint pain
NeurologicalNegativeNo tremor or headache

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cyclosporine (modified) 100 mg oral capsule, one capsule twice daily, dose adjusted to trough levels by hematologyOne capsule by mouth twice daily; hematology adjusts the dose to trough levelsOral route1934-05-18activeS
Eltrombopag 75 mg oral tablet, two tablets (150 mg) once daily on an empty stomachTwo tablets by mouth once daily, two hours before or four hours after food, dairy, or antacidsOral route1934-05-18activeS
Acyclovir 400 mg oral tablet, one tablet twice daily during immunosuppressionOne tablet by mouth twice dailyOral route1934-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1934-06-08Body height157cmS
1934-06-08Body weight51.5kgS
1934-06-08Body mass index (BMI) [Ratio]20.9kg/m2S
1934-06-08Systolic blood pressure124mm[Hg]S
1934-06-08Diastolic blood pressure76mm[Hg]S
1934-06-08Heart rate90/minS
1934-06-08Respiratory rate16/minS
1934-06-08Body temperature36.8CelS
1934-06-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1934-06-08Hemoglobin [Mass/volume] in Blood8.2g/dL11.6-15 g/dLLowS
1934-06-08Leukocytes [#/volume] in Blood by Automated count210*3/uL4-11 10*3/uLLowS
1934-06-08Neutrophils [#/volume] in Blood by Automated count0.510*3/uL1.5-7.5 10*3/uLLowS
1934-06-08Platelets [#/volume] in Blood by Automated count2110*3/uL150-400 10*3/uLLowS
1934-06-08MCV [Entitic mean volume] in Red Blood Cells by Automated count102fL80-100 fLHighS
1934-06-08Reticulocytes [#/volume] in Blood by Automated count1810*3/uL25-100 10*3/uLLowS
1934-06-08Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-35 U/LNormalS
1934-06-08Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1934-06-08Potassium [Moles/volume] in Serum or Plasma4.8mmol/L3.5-5.1 mmol/LNormalS
1934-06-08Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.59-1.04 mg/dLNormalS
1934-06-08Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1929)/1.73 sq M65mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1934-06-08Glucose [Mass/volume] in Serum or Plasma101mg/dL70-99 mg/dLHighS

Physical Exam

Vital signs recorded on 1934-06-08; see the Vital Signs section. [S]

SystemFinding
GeneralPale but less tired-looking; alert
MouthNo ulcers, thrush, or gum swelling
SkinA few bruises on the shins; no petechiae or rash
HeartRegular rhythm, pulse 90
EyesRight red reflex hazy, with glare on penlight; left red reflex clear

Problems

ProblemClinical statusVerificationCodeProvenance
Severe aplastic anemia: pancytopenia with a low reticulocyte count, confirmed by a hypocellular bone marrow; attributed to cumulative occupational ionizing radiation; linked to the documented 1842 diagnosisactiveconfirmed D61.2S — Synthetic modern diagnosis; the 1934 report remains D and the radiation cause is R.
Occupational exposure to ionizing radiation over decades of radium research and X-ray workactiveconfirmed Z57.1S — Synthetic modern coding of the documented exposure history.
Posterior capsule opacification, right eye, after earlier bilateral cataract surgery; glare and blurred reading visionactiveconfirmed H26.491S — Synthetic eye finding linked to the documented cataracts and operations.
Chronic radiodermatitis of the fingertips, with thin, scarred skinactiveconfirmed L58.1S — Synthetic skin finding linked to the documented finger burns.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryCBC with differential and reticulocyte countWeekly during the first months of treatmentCompleted todayHemoglobin 8.2 g/dL, white cells 2.0, neutrophils 0.5, platelets 21, reticulocytes 18 thousand per microliter
LaboratoryWeekly blood counts between visitsWeekly during the first months of treatmentDeferredNo counts are in this record between the consultation and today, so two weekly counts were missed, a deviation from the protocol. Platelets stayed above 15 and there was no bleeding or fever, so no harm resulted. Corrective action: weekly counts booked with the hematology day unit
LaboratoryCreatinine, eGFR, potassium, and ALT on cyclosporine and eltrombopagEvery two weeks during the first months of treatmentCompleted todayFirst check, three weeks after starting, a week later than the two-week schedule. Creatinine 0.96 mg/dL (up from 0.78), eGFR 65, potassium 4.8, ALT 28, sodium 138; glucose 101 mg/dL, slightly high
LaboratoryCyclosporine trough levelRegularly from the first weeks of treatment, to guide the doseDeferredNo trough level is in this record since cyclosporine started, a deviation from the protocol. The creatinine rise may reflect cyclosporine effect. Corrective action: trough requested from hematology with the next counts
LaboratoryViral serology before immunosuppression (hepatitis B, hepatitis C, HIV, CMV, EBV)At diagnosis, before immunosuppressionDeferredStill not in this record; not sent with today's blood, a second miss. ALT is normal, with no sign of hepatitis. Corrective action: results requested from hematology
ExaminationBlood pressure and weight on cyclosporineEvery visitCompleted today124/76 mmHg, up from 116/70 before cyclosporine; weight 51.5 kg
Medication safetyAntiviral prophylaxis during immunosuppressionThroughout immunosuppressionCompleted todayTaking acyclovir twice daily
Medication safetyAntibacterial and antifungal prophylaxis while severely neutropenicWhile neutrophils are below 0.5 thousand per microliter, by local policyDeferredStill not prescribed; neutrophils 0.5, at the threshold, with no infection. Hematology to confirm under local policy
Medication safetyEltrombopag administrationEvery visitCompleted todayTaken on an empty stomach, away from dairy and antacids
Self-managementSame-day assessment for a temperature of 38 °C or higher; bleeding precautions; no aspirin or NSAIDsEvery visitCompleted todayNo fever; plan reviewed
SurveySymptom assessment (fatigue, breathlessness, exercise tolerance)Every visit during active treatmentCompleted todayTired by midafternoon; breathless after one flight of stairs
SurveyFunctional vision assessment (reading, driving, work)When symptoms limit daily tasksCompleted todayGlare limits small print, reading, and night driving
ReferralComprehensive dilated eye examinationEvery 1 to 2 years at 65 or older, and with new functional impairmentReferredOphthalmology appointment next week
SurveyResponse assessment (blood counts off transfusion)At three and six monthsDueFormal response is judged at three months
SurveyDepression screen (PHQ-2)Periodically during serious illnessDueScore 1 at intake; repeat at the next visit

Goal progress:

Guideline basis: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024); Cataract in the Adult Eye Preferred Practice Pattern (2021); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026)

Follow-up: Weekly blood counts. Ophthalmology next week. Primary care review in three weeks with blood counts, kidney function, potassium, and ALT. Next scheduled visit 1934-06-29: primary care follow-up six weeks into immunosuppressive therapy, after laser capsulotomy of the right eye. [S]